Features | Partner Sites | Information | LinkXpress
Sign In
Samsung
Shuenn Bao Shing Corporation
SOREDEX

Blood Test Measures Hodgkin’s Chemotherapy Success

By HospiMedica International staff writers
Posted on 06 Mar 2013
A cheap and easy to use diagnostic test helps determine the success of chemotherapy in patients enduring Hodgkin’s lymphoma (HL).

Researchers at the Queensland Institute of Medical Research (QIMR; Brisbane, Australia), the University of Melbourne (Australia), and other institutions prospectively measured serum CD163 (sCD163) and the Hodgkin-Reed-Sternberg (HRS)-specific serum protein sTARC in 221 samples taken from 47 patients with HL, and 21 healthy participants. Blood was drawn at five fixed time-points prior, during, and after first-line therapy. The results were compared with radiological assessment and plasma Epstein-Barr virus DNA (EBV-DNA). The researchers also examined potential sources of circulating CD163, as well as immunosuppressive properties of CD163.

The results showed that prior to therapy, both sCD163 and sTARC were markedly elevated compared with healthy and complete remission samples; sCD163 better reflected tumor burden during therapy, and sTARC presenting greater value upon completion of therapy. Additionally, sCD163 correlated with plasma EBV-DNA, and was associated with B symptoms, stage, and lymphopenia. The researchers found that the combination of both proteins was more informative as a disease response biomarker than either marker alone, in early and advanced disease during first-line therapy for classical HL. The study was published in the February 2013 issue of Clinical Cancer Research.

“This has the potential to be a huge aid for doctors in their decision making and a faster and less invasive process for the patients. Up until now, clinicians have relied on scans to help them judge how well people are responding to chemotherapy,” said lead author Professor Maher Gandhi, PhD, of the QIMR Clinical Immunohaematology Laboratory. “This discovery means we can work towards using simple blood tests to provide quicker, cheaper, and more regular monitoring of how a person is responding to treatment.”

Response biomarkers for classical HL might arise from Hodgkin-Reed-Sternberg (HRS) cells or nonmalignant tumor-infiltrating cells. While HRS cells are sparse within the diseased node, benign CD163(+) M2 tissue-associated macrophages (TAM) are prominent. It is known that CD163(+) cells within the malignant node may be prognostic, but until now there has been no data on serum CD163.

Related Links:

Queensland Institute of Medical Research
University of Melbourne



Anetic Aid
CardioComm Solutions
Dunlee

Channels

Surgical Techniques

view channel

Nerve Block Procedure Safe for Children

Caudal nerve block in children has a low complication rate, with little or no risk of long-term adverse effects, according to a new study. Researchers at Northwestern University (Chicago, IL, USA) conducted an observational study involving 18,650 children to estimate the overall and specific incidence of complications... Read more

Women's Health

view channel

Women with PTSD Face Higher Pregnancy Risk

Suffering from post-traumatic stress disorder (PTSD) significantly increases a pregnant woman's risk of premature birth, according to a new study. Researchers at Stanford University (CA, USA) conducted a study to identify antenatal PTSD status and spontaneous preterm delivery in a retrospective cohort (2000-2012).... Read more

Health IT

view channel

Wikipedia Page Views Could Predict Disease Outbreaks

A new study suggests that Wikipedia access data could be an effective tool for forecasting disease outbreaks up to a month in advance. Researchers at the Los Alamos National Laboratory (NM, USA) reviewed access logs to disease-related Wikipedia pages between 2010 and 2013. They mapped the languages the information was... Read more

Hospital News

view channel

Unused US Medical Supplies Could Support Hospitals Abroad

Major hospitals across the United States collectively throw away at least USD 15 million a year in unused operating room (OR) surgical supplies that could be salvaged and used to ease critical shortages, improve surgical care, and boost public health in developing countries. Researchers at Johns Hopkins Hospital (JHH;... Read more

Business

view channel

Global Wound Care Market Rife With Opportunity

Strong relationships with end users and an effective post sales service strategy must be a priority for wound care companies. These are the latest findings of Frost & Sullivan (Frost; London, United Kingdom), an international market research firm. The global wound care market is at a growth stage, driven by the increasingly... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.